Clinical Trial Update: Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a regimen of doxorubicin and cyclophosphamide followed by trastuzumab, paclitaxel, and lapatinib in early-stage HER2-positive breast ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Lapatinib (Lapatinib)
• PACLITAXEL (PACLITAXEL)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Breast Cancer, Cardiac Toxicity | Phase 2 | Status: COMPLETED | Results posted: 2012-11-21